The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
from NDTV News - Latest https://ift.tt/3rRLYFo
google-site-verification: googlec4cd9e582f984ac6.html
No comments:
Post a Comment